Volume is here for a reason, massive $6.8bil future market share predicted, plenty of room
for share price to rise only $30m market cap. 20+ cents is achievable.
To many looking in the review mirror & not the future.
Past does not reflect on the future, Gold stocks were down, now look, back up they go.
CPH has a large range of products & are now also expanding for a larger piece of
the market share purchasing HHI, & developing Halucenex with positive results.
DYOR
- Forums
- ASX - By Stock
- Ann: Halucenex Phase II Clinical Trial Update
Volume is here for a reason, massive $6.8bil future market share...
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)